You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucokinase

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Charlottesville (Metformin, Insulin Glargine, Dorzagliatin)

Recruiting
  • Type 2 Diabetes
  • Charlottesville, Virginia
    Rita Basu
Jul 19, 2022

Diabetes, Type 2 Trial in Shanghai (HMS5552, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Shanghai, China
    Hua Medicine Limited
Aug 24, 2021

Diabetes, Type 2 Trial in Shanghai (HMS5552, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Shanghai, Shanghai, China
    Hua Medicine Limited
Aug 24, 2021

Type 2 Diabetes Trial in Chula Vista, San Antonio (ARRY-403, glucokinase activator; oral, Placebo; oral)

Completed
  • Type 2 Diabetes
  • ARRY-403, glucokinase activator; oral
  • Placebo; oral
  • Chula Vista, California
  • +1 more
Oct 2, 2020

Type2 Diabetes Trial in Beijing (glucokinase activator, Placebo)

Completed
  • Type2 Diabetes Mellitus
  • glucokinase activator
  • Placebo
  • Beijing, China
    Peking University Third Hospital
Jan 21, 2020

ST-segment Elevation Myocardial Infarction (STEMI) Trial in China (Recombinant Staphylokinase, Normal Saline)

Active, not recruiting
  • ST-segment Elevation Myocardial Infarction (STEMI)
  • Recombinant Staphylokinase
  • Normal Saline
  • Nanjing, Jiangsu, China
  • +7 more
Jan 30, 2023

Type 2 Diabetes, Diabetes, Type 2, Renal Transplant Trial in London (AZD1656, Placebo)

Recruiting
  • Type 2 Diabetes
  • +4 more
  • London, United Kingdom
    Royal London Hospital Barts Health NHS Trust
Feb 4, 2022

The Progress of Diabetes Mellitus After HMS5552 Treatment in

Unknown status
  • Type2 Diabetes Mellitus
  • Nanjing, Jiangsu, China
    Nanjing First hospital
Aug 25, 2021

Glucose Intolerance Trial (Dorzagliatin, Placebo)

Not yet recruiting
  • Glucose Intolerance
  • (no location specified)
Jul 21, 2022

Maturity-onset Diabetes of the Young, Monogenic Diabetes, MODY Trial (Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A,

Not yet recruiting
  • Maturity-onset Diabetes of the Young
  • +2 more
  • Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)
  • (no location specified)
Oct 19, 2022

Patients Trial in Hackensack (Empagliflozin, Dorzagliatin)

Completed
  • Patients
  • Hackensack, New Jersey
    Frontage Clinical Services Inc.
Mar 24, 2020

Healthy Volunteers Trial in Singapore (LY2608204 Reference, LY2608204 Test)

Completed
Has Results
  • Healthy Volunteers
  • LY2608204 Reference
  • LY2608204 Test
  • Singapore, Singapore
    For additional information regarding investigative sites for thi
Oct 4, 2018

Maturity-Onset Diabetes of the Young Trial in Paris (insulin therapy)

Completed
  • Maturity-Onset Diabetes of the Young
  • insulin therapy
  • Paris, France
    La Pitié Salpêtrière Hospital
Apr 16, 2021

Acute Myocardial Infarction Trial in China (Recombinant Staphylokinase, normal saline)

Completed
  • Acute Myocardial Infarction
  • Recombinant Staphylokinase
  • normal saline
  • Nanjing, Jiangsu, China
  • +8 more
Jan 12, 2023

Patients Trial in Hackensack (Sitagliptin, Dorzagliatin)

Completed
  • Patients
  • Hackensack, New Jersey
    Frontage Clinical Services Inc.
Sep 22, 2019

Diabetes, Type 2 Trial in Miramar, Singapore (LY2608204)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Miramar, Florida
  • +1 more
Oct 18, 2018

Type 2 Diabetes Trial in Los Angeles (Liraglutide)

Withdrawn
  • Type 2 Diabetes
  • Los Angeles, California
    Cedars Sinai Medical Center
Sep 26, 2019

Diabetes, Type 2 Trial in Hong Kong (Dorzagliatin, )

Completed
  • Diabetes Mellitus, Type 2
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Jul 19, 2022

DHB Supplement Interaction Study

Withdrawn
  • Healthy Volunteers
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Apr 21, 2020

    Newly Diagnosed Type 2 Diabetes Trial in Parma (Metformin-Sitagliptin-Empaglifozin-Pioglitazone, Standard of care)

    Recruiting
    • Newly Diagnosed Type 2 Diabetes
    • Parma, Italy
      Azienda Ospedaliero Universitaria di Parma
    Aug 10, 2021

    Overweight and Obesity, Stunted Growth, Malnutrition, Child Trial in Mérida (Experimental intervention group with enriched

    Completed
    • Overweight and Obesity
    • +3 more
    • Experimental intervention group with enriched cookies
    • Mérida, Yucatán, Mexico
      Facultad de Química, Unidad Académica de la UNAM en Yucatán
    May 31, 2021

    Permanent Neonatal Diabetes Trial in Bergen (Sulfonylurea)

    Unknown status
    • Permanent Neonatal Diabetes Mellitus
    • Bergen, Norway
      Haukeland University Hospital
    Feb 10, 2020

    ß-cell Specific Glucokinase Mutation on Glucose Homeostasis and

    Unknown status
    • MODY-2 Diabetes
    • OGTT
    • ramat Gan, Israel
      Sheba Medical Center
    Jun 18, 2017

    Diabetes, Type 2 Trial in Nanjing (HMS5552, Placebo)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Nanjing, Jiangsu, China
      Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing U
    Feb 25, 2020

    Maturity-Onset Diabetes of the Young, Type 3, Maturity Onset Diabetes of the Young, Type 1, Childhood Diabetes Trial in Bergen

    Unknown status
    • Maturity-Onset Diabetes of the Young, Type 3
    • +3 more
    • Bergen, Norway
      Department of Pediatrics and Adolescents, Haukeland University H
    Jan 21, 2020